Trial intelligence / Profile preview

Pregabalin for Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer

NCT00380874Phase 4Terminated

Sponsor
Viatris
Start
Jan 2007
Primary completion
Mar 2008
Modality
Small Molecules
Countries
6
01

Overview

A Phase 4 trial of pregabalin in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by Viatris. Started Jan 2007; status: terminated.

02

Drugs

pregabalin
03

Conditions

chemotherapy-induced peripheral neuropathy (CIPN)

Beyond the preview

Go deeper on NCT00380874.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00380874.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call